Stepan Company
SCLBasic MaterialsNASDAQSpecialty Chemicals
Scan Results
Daily timeframeStepan Company, together with its subsidiaries, produces and sells specialty and intermediate chemicals to other manufacturers for use in various end products in the United States, France, Poland,. With a market capitalization of $1.45B, it sits in small-cap territory. It operates through three segments: Surfactants, Polymers, and Specialty Products.
Market Cap
$1.45B
Beta
0.95
P/E (TTM)
—
P/E (Fwd)
17.32
EPS (TTM)
$-0.12
EPS (Fwd)
$3.69
ROE
-0.2%
ROA
2.1%
Cash
$113.7M
Total Debt
$707.3M
Free CF
$55.5M
52W Change
38.5%
Annual Financials
Cash vs Debt
Where SCL stands vs its 150-day and 200-day moving averages
As of the October 5, 2026 close, SCL finished 14.15% above its 150-day moving average ($55.19) and 15.05% above its 200-day moving average ($54.76). This snapshot is end-of-day data shown with a five-trading-day delay on the free plan; Premium members see readings from the latest close.
Is SCL overbought or oversold?
At the October 5, 2026 close, SCL's RSI(14) was 57.6, in neutral territory (between 30 and 70). The MACD histogram was negative, so short-term momentum leaned bearish at that close. These readings are historical, refresh daily after market close, and are not investment advice.
On the balance sheet, SCL has $113.7M in cash with $707.3M in obligations. The ability to service this debt comfortably depends on continued operational cash generation. Free cash flow comes in at $55.5M, providing flexibility for reinvestment, buybacks, or dividends. Consistent free cash flow generation is often considered a sign of operational health. ROE of -0.2% points to negative capital efficiency, indicating how much profit the company produces per dollar of shareholder equity. ROA of 2.1% is on the lower side, which is common in asset-heavy industries. Revenue has pulled back from $2.77B (2022) to $2.33B (2025), a 16% decline worth watching.
Debt significantly exceeds cash reserves, which means the company's financial flexibility could be constrained during economic downturns. No single metric tells the full story. Reviewing SCL's risk profile alongside its fundamentals and technical indicators provides a more complete picture.